COMMUNIQUÉS West-GlobeNewswire

AIM ImmunoTech Announces Pricing of $8.0 Million Public Offering
29/07/2025
OCALA, Fla., July 29, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (the “Company”), today announced the pricing of a public offering of an aggregate of 2,000,000 shares of its common stock (or pre- [...]
LogicMark, Inc. to Announce Second Quarter 2025 Financial Results on August 12, 2025
29/07/2025
LOUISVILLE, Ky., July 29, 2025 (GLOBE NEWSWIRE) -- LogicMark, Inc. (OTC: LGMK), a provider of emergency response systems, health communications devices, and technology for the growing personal safety and care economy, [...]
Windtree Therapeutics Announces Large Reduction of Preferred Series C and D Shares Outstanding by Conversion and Redemption
29/07/2025
Investors choose to redeem or convert the majority of Series C and Series D Preferred 99% of outstanding preferred series C shares are redeemed or converted and preferred series D reduced 68.5% in outstanding shares BNB [...]
Akari Therapeutics Releases Virtual Investor “What This Means” Segment
29/07/2025
Abizer Gaslightwala, President and CEO of Akari Therapeutics discussed Akari’s commitment to continued research to better understand the multiple effects of its novel spliceosome modulator, PH1 Watch the “What This [...]
BioPorto A/S to host an investor webcast on the results for the first half of 2025
29/07/2025
July 29, 2025 News release BioPorto A/S to host an investor webcast on the results for the first half of 2025 COPENHAGEN, DENMARK, July 29, 2025 (GLOBE NEWSWIRE) – BioPorto A/S (BioPorto or the Company) (CPH:BIOPOR), [...]
Monogram Technologies Announces World’s First Fully Autonomous Saw-Based Robotic Knee Replacement Surgery
29/07/2025
The Procedure Utilized Monogram’s mBôs TKA System Performed in India with Shalby Hospitals Groundbreaking Procedure Delivers the World’s First Autonomous Saw-Based Robotic TKA Surgery on a Live Patient AUSTIN, Texas, [...]
AscellaHealth HUB Partnership with Abeona Therapeutics® Supports Launch Success of Novel Cell-Based Gene Therapy and Access to Treatment for Rare Disease Patients
29/07/2025
BERWYN, Pa., July 29, 2025 (GLOBE NEWSWIRE) -- AscellaHealth , a global partner delivering customizable solutions to support the specialty pharmaceutical industry, highlights the value of its HUB partnership with Abeona [...]
Altanine Names Charles J. Andres, Ph.D., J.D., as CEO to Lead Clinical and Strategic Expansion
29/07/2025
LOS ANGELES, July 29, 2025 (GLOBE NEWSWIRE) -- Altanine, Inc., a pharmaceutical company advancing proprietary drug delivery technologies across high-growth therapeutic areas, today announced the appointment of Charles J [...]
Bio Usawa Biotechnology and Sartorius Stedim Biotech Forge Partnership to Pioneer Biopharmaceutical Manufacturing in Africa
29/07/2025
KIGALI, Rwanda and SAN FRANCISCO and AUBAGNE, France, July 29, 2025 (GLOBE NEWSWIRE) -- Bio Usawa Biotechnology, Ltd. (Bio Usawa), a leading African biotechnology firm, and Sartorius Stedim Biotech, a global partner of [...]
2025 Adam Ferrari Health Science Scholarship Application Window Closes with Strong Response
29/07/2025
The Adam Ferrari Health Science Scholarship has closed its application window and will announce a recipient from the pool of applicants in August 2025. IRVINE, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- The application [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 30 - 2025
29/07/2025
Aggregated presentation by day and by market Statement of transactions in own shares from July 21st to July 25th 2025 Name of the issuer Identity code of the issuer (Legal Entity Identifier) Day of the transaction [...]
CorTec Announces Neurotech Milestone: First Human Implantation of a Brain-Computer Interface made in Germany
29/07/2025
The closed-loop BCI system, developed entirely in Germany, is currently being evaluated in an FDA-approved clinical trial with stroke patients at Harborview Medical Center in Seattle, a part of UW Medicine FREIBURG, [...]
IHA’s Symphony Goes Live as Provider Directory Data Source for Covered California
29/07/2025
Now live, Symphony helps the nation’s largest Affordable Care Act marketplace provide accurate, real-time provider directory data while enrollees shop and compare health insurance plans OAKLAND, Calif., July 29, 2025 ( [...]
Krystal Biotech to Report Second Quarter 2025 Financial Results on August 4, 2025
29/07/2025
PITTSBURGH, July 29, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that it will report its second quarter 2025 financial results [...]
Harrow To Report Second Quarter 2025 Financial Results After Market Close on August 11, 2025
29/07/2025
Company to Host Conference Call to Discuss Results at 8:00 a.m. Eastern Time on August 12, 2025 NASHVILLE, Tenn., July 29, 2025 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical [...]
Pharmazz Inc. Announces Enrollment of First Patient in Phase 3 Clinical Trial of Sovateltide for Treating Patients with Cerebral Ischemic Stroke
29/07/2025
The Phase 3 clinical trial of sovateltide, RESPECT-ETB, is expected to enroll over 500 patients with a primary endpoint of proportion of patients demonstrating functional independence at 90 days and is being conducted [...]
INmune Bio to Publish Video Detailing MINDFuL Trial Findings of XPro™ Presented at the Alzheimer’s Association International Conference
29/07/2025
Boca Raton, July 29, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) announced today that a video detailing the additional findings from the Phase 2 MINDFuL trial evaluating XPro™, a novel selective soluble TNF [...]
Sight Sciences Announces the Publication of the 24-Month Results of the SAHARA RCT Demonstrating the Durability of the TearCare® Procedure for the Treatment of Dry Eye Disease
29/07/2025
Mean signs and symptoms for participants in Stage 3 of the SAHARA trial remained statistically significantly better than study baseline at all time points measured up to 24 months MENLO PARK, Calif., July 29, 2025 ( [...]
Castle Biosciences to Present at the Canaccord Genuity 45th Annual Growth Conference
29/07/2025
FRIENDSWOOD, Texas, July 29, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its executive management [...]

Pages